Idris, I. (2024). Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied. Wiley. https://doi.org/10.1002/doi2.109
Chicago Style (17th ed.) CitationIdris, Iskandar. Potential New Therapies to Preserve Lean Muscle Mass Loss When Used in Combination with Glucagon‐like Peptide 1 (GLP‐1) Receptor Agonist Being Studied. Wiley, 2024. https://doi.org/10.1002/doi2.109.
MLA (9th ed.) CitationIdris, Iskandar. Potential New Therapies to Preserve Lean Muscle Mass Loss When Used in Combination with Glucagon‐like Peptide 1 (GLP‐1) Receptor Agonist Being Studied. Wiley, 2024. https://doi.org/10.1002/doi2.109.
Warning: These citations may not always be 100% accurate.